Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 135 - What They Never Told You

US-level mortality? Sounding the alarm about fentanyl overdose in Australia

Deaths from the powerful opioid, along with pethidine and tramadol, are up a staggering 1,275% since 2006. A new report warns without ‘decisive action’ a crisis looms

The Guardian - AU

Pfizer criticised by conservatives for excluding white and Asian applicants from scholarship programme

Company says scheme will boost minority representation

The Independent UK

FDA still skeptical of ALS drug ahead of high-stakes meeting

The U.S. Food and Drug Administration has posted another negative review of a closely watched drug for the deadly neurodegenerative disease ALS

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Completely new’ COVID strains possible in winter: EU drug agency

Existing vaccines and adaptive ones should protect people from serious illness and death, the EU agency says.

Al Jazeera

Is Cannabis Legalization The End For Pharma Stocks? New Study Predicts Billions In Losses

Federal cannabis legalization might reduce conventional pharmaceutical sales by billions of dollars according to a new study cond

Benzinga

EU regulator gives green light to omicron booster vaccines

The European Medicines Agency (EMA) has backed two separate Covid-19 booster vaccines updated to target the omicron variant of Covid-19 and developed by drugmakers Moderna and BioNTech-Pfizer.

Radio France Internationale

New omicron COVID-19 boosters are coming. Here’s what you need to know

DENVER — COVID-19 booster shots with a new omicron-targeting recipe are expected to arrive in pharmacies and clinics next week, but the experience of getting them will be largely the same as previous rounds of the vaccine.

The Denver Post

Read news from The Economist, FT, and more,
with one subscription

"Game-changer" Paxlovid turns into pandemic enigma

Paxlovid goes from COVID game-changer to pandemic enigma

Axios

Alliance Pharma boss faces disqualification after CMA probe

The healthcare firm denies conspiring to restrict the supply of anti-sickness drugs to the NHS

Evening Standard

CDC recommends updated COVID-19 boosters

The CDC recommends the new Pfizer-BioNTech booster for individuals 12 years and the Moderna vaccine for individuals 18 and up.

Axios

Innobic in talks with potential partner

Innobic (Asia) Co, the life science arm of national oil and gas conglomerate PTT Plc, is seeking a new business partner in Iceland in a fresh move to produce medicines to treat cancer.

Bangkok Post

Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics

Optimi Health (OTCQX: OPTHF) has released an operational update on its planned year of commercialization, including the launch of psychedelics catalog.

Benzinga

CDC advisers weigh who needs updated COVID booster and when

Government advisers are debating who should should get new updated COVID-19 boosters and when

The Independent UK

EU regulator backs use of Novavax COVID shot as a booster

The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.

Reuters

Get all your
news in one place.

100's of premium titles.
One news app.

Bangkok Post

EU regulator approves Omicron vaccines

The European Union’s drug regulator has recommended the use of two Omicron-tailored vaccines developed by the Pfizer-BioNTech partnership and Moderna Inc ahead of a fresh booster programme this fall across the continent.

Benzinga

Everest Medicines Descends To New Depths On String Of Bad News

Key Takeaways: The CEO of Everest Medicines resigned two days after the company announced its loss grew sharply in the first half of the year The company also lost an important potential new revenue source after transferring rights for one of its core products to another company By Emily Chan

The Independent UK

EU regulator clears tweaked versions of COVID vaccines

The European Medicines Agency has recommended the authorization of two coronavirus vaccines made by Pfizer-BioNTech and Moderna Inc., tweaked to include protection against an early version of the omicron variant

ABC News

Brisbane biotech firm Ellume puts Australian arm into administration

Ellume rose to prominence last year when it announced a $300 million deal to provide COVID-19 home test kits to the US Department of Defense.

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Michael Hiltzik: In blow to public health, judge tosses FDA lawsuit targeting a clinic offering unproven stem cell treatments

A federal judge in Riverside, California, declared a stem cell treatment firm operating in the state to be exempt from Food and Drug Administration regulations, opening the door to the further proliferation of clinics offering therapies the FDA says are scientifically unproven and potentially dangerous.

Benzinga

Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy

Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million.

Reason

FDA Approves Updated COVID-19 Booster Shots

But does everyone really need to get boosted?

Benzinga

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

Tribune News Service

FDA clears way for boosters targeted at latest COVID variants

COVID-19 boosters from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE that are tailored to the latest COVID-19 omicron variants got U.S. regulatory clearance, a move toward additional protection as concern grows about potential new waves in the fall and winter.

The Independent UK

US clears updated Covid boosters targeting the newest Omicron strain

Omicron booster shots could become available within days

Axios

FDA authorizes Omicron boosters

The updated shots are expected to become available after Labor Day.

1 … 134 135 136 137

People

Buranin Rattanasombat

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

349 stories

Pfizer Inc

313 stories

Department of Defense

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.